We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.54%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$96.4B
AUM Growth
-$1.4B
(-1.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
280
New
10
Increased
138
Reduced
66
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$363M |
| 3 |
American Airlines Group
AAL
|
+$310M |
| 4 |
CarMax
KMX
|
+$258M |
| 5 |
FedEx
FDX
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$779M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$394M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 4 |
Bath & Body Works
BBWI
|
+$134M |
| 5 |
GSK
GSK
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 23.79% |
| 3 | Industrials | 15.28% |
| 4 | Consumer Discretionary | 9.12% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Honeywell
HON
$77.7B
| $544M | 0.56% |
5,404,490
-21,045
| -0.4% | -$1.97M |
|
|
ABMD
52
DELISTED
Abiomed Inc
ABMD
| $525M | 0.54% |
5,535,290
-121,800
| -2% | -$10.3M |
|
53
Royal Caribbean
RCL
$85.8B
| $482M | 0.5% |
5,869,872
+792,071
| +16% | +$61.8M |
|
|
SGEN
54
DELISTED
Seagen Inc. Common Stock
SGEN
| $477M | 0.49% |
13,589,187
+707,012
| +5% | +$23.7M |
|
55
Caterpillar
CAT
$389B
| $476M | 0.49% |
6,219,249
+135,248
| +2% | +$9.07M |
|
|
QGENF
56
DELISTED
QIAGEN NV
QGENF
| $458M | 0.47% |
20,493,375
-38,950
| -0.2% | -$870K |
|
57
JetBlue
JBLU
$2.27B
| $425M | 0.44% |
20,142,714
+35,200
| +0.2% | +$740K |
|
58
Progressive
PGR
$125B
| $413M | 0.43% |
11,766,525
+86,200
| +0.7% | +$2.76M |
|
59
United Parcel Service
UPS
$88.7B
| $409M | 0.42% |
3,880,998
+8,000
| +0.2% | +$777K |
|
60
Deere & Co
DE
$168B
| $407M | 0.42% |
5,286,519
+856,000
| +19% | +$67M |
|
61
Corning
GLW
$144B
| $405M | 0.42% |
19,378,500
+31,800
| +0.2% | +$590K |
|
62
Union Pacific
UNP
$176B
| $373M | 0.39% |
4,693,100
-7,300
| -0.2% | -$564K |
|
|
63
AstraZeneca
AZN
$249B
| $368M | 0.38% |
6,542,138
+6,047,688
| +1,223% | +$363M |
|
64
CVS Health
CVS
$122B
| $368M | 0.38% |
3,548,780
+3,710
| +0.1% | +$361K |
|
65
Jacobs Solutions
J
$17.1B
| $356M | 0.37% |
9,875,840
+407,151
| +4% | +$13.3M |
|
66
Illumina
ILMN
$28.8B
| $353M | 0.37% |
2,235,664
+607
| +0% | +$92.8K |
|
|
ELLI
67
DELISTED
Ellie Mae Inc
ELLI
| $350M | 0.36% |
3,861,950
-22,600
| -0.6% | -$1.69M |
|
|
ATVI
68
DELISTED
Activision Blizzard
ATVI
| $350M | 0.36% |
10,334,800
+21,450
| +0.2% | +$703K |
|
69
Trimble
TRMB
$13.7B
| $330M | 0.34% |
13,319,816
+230,400
| +2% | +$5.09M |
|
70
SLB Ltd
SLB
$76.2B
| $328M | 0.34% |
4,443,971
-4,353
| -0.1% | -$306K |
|
|
71
Johnson & Johnson
JNJ
$618B
| $327M | 0.34% |
3,023,678
-7,519,884
| -71% | -$779M |
|
72
Oracle
ORCL
$421B
| $317M | 0.33% |
7,751,850
-939,275
| -11% | -$34.8M |
|
|
DWA
73
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $292M | 0.3% |
11,696,200
| – | – |
|
|
ETFC
74
DELISTED
E*Trade Financial Corporation
ETFC
| $278M | 0.29% |
11,343,300
+5,087,900
| +81% | +$123M |
|
75
Nektar Therapeutics
NKTR
$2.53B
| $275M | 0.29% |
1,334,006
+15,054
| +1% | +$2.89M |
|
Similar funds
VAM
Primecap Management's Q1 2016 Portfolio in Review
As of Q1 2016, Primecap Management held 280 positions worth $96.4B, down 1.4% from $97.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management's Q1 2016 filing shows 10 new, 138 increased, 66 reduced and 10 closed positions. Its largest new stake was Northern Trust: 1,775,400 shares worth $116M. The largest sale was Johnson & Johnson, an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2016 buy was Northern Trust: 1,775,400 shares worth $116M.
- Primecap Management added most to AstraZeneca in Q1 2016, an estimated $363M increase.
- Primecap Management's biggest Q1 2016 reduction was Johnson & Johnson, cutting an estimated $779M.
- Primecap Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $394M.
- Primecap Management's ten largest holdings make up 34% of its $96.4B portfolio in Q1 2016.
- Primecap Management opened 10 new positions and closed 10 in Q1 2016.
- Primecap Management's portfolio value fell 1.4% quarter-over-quarter to $96.4B.
Based on Primecap Management's 13F filing for Q1 2016, filed 12 May 2016.